Pancreatic Cancer - Global Market Outlook (2017-2026)

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Pancreatic Cancer Market, By Treatment
5.1 Introduction
5.2 Biologic Therapy
5.3 Hormone Therapy
5.4 Chemotherapy
5.5 Targeted Therapy
5.6 Surgery
5.7 Radiation Therapy
5.8 Other Treatments

6 Global Pancreatic Cancer Market, By Type
6.1 Introduction
6.2 Exocrine Pancreas Cancer
6.3 Endocrine Pancreas Cancer

7 Global Pancreatic Cancer Market, By End User
7.1 Introduction
7.2 Research Institute
7.3 Hospitals & Clinics
7.4 Other End Users

8 Global Pancreatic Cancer Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Novartis Ag
10.2 Eli Lily and Company
10.3 F. Hoffmann-La Roche AG
10.4 Pharmacyte Biotech, Inc
10.5 Clovis Oncology
10.6 Celgene Corporation
10.7 Teva Pharmaceutical Industries Ltd.
10.8 Amgen, Inc.
10.9 Pfizer, Inc.
10.10 Merck & Co., Inc.

List of Tables
1 Global Pancreatic Cancer Market Outlook, By Region (2016-2026) (US $MN)
2 Global Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
3 Global Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
4 Global Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
5 Global Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
6 Global Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
7 Global Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
8 Global Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
9 Global Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
10 Global Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
11 Global Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
12 Global Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
13 Global Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
14 Global Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
15 Global Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
16 Global Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
17 North America Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN)
18 North America Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
19 North America Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
20 North America Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
21 North America Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
22 North America Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
23 North America Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
24 North America Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
25 North America Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
26 North America Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
27 North America Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
28 North America Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
29 North America Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
30 North America Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
31 North America Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
32 North America Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
33 Europe Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN)
34 Europe Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
35 Europe Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
36 Europe Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
37 Europe Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
38 Europe Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
39 Europe Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
40 Europe Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
41 Europe Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
42 Europe Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
43 Europe Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
44 Europe Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
45 Europe Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
46 Europe Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
47 Europe Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
48 Europe Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
49 Asia Pacifc Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN)
50 Asia Pacifc Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
51 Asia Pacifc Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
52 Asia Pacifc Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
53 Asia Pacifc Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
54 Asia Pacifc Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
55 Asia Pacifc Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
56 Asia Pacifc Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
57 Asia Pacifc Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
58 Asia Pacifc Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
59 Asia Pacifc Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
60 Asia Pacifc Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
61 Asia Pacifc Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
62 Asia Pacifc Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
63 Asia Pacifc Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
64 Asia Pacifc Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
65 South America Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN)
66 South America Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
67 South America Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
68 South America Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
69 South America Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
70 South America Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
71 South America Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
72 South America Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
73 South America Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
74 South America Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
75 South America Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
76 South America Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
77 South America Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
78 South America Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
79 South America Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
80 South America Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
81 Middle East & Africa Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN)
82 Middle East & Africa Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
83 Middle East & Africa Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
84 Middle East & Africa Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
85 Middle East & Africa Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
86 Middle East & Africa Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
87 Middle East & Africa Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
88 Middle East & Africa Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
89 Middle East & Africa Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
90 Middle East & Africa Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
91 Middle East & Africa Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
92 Middle East & Africa Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
93 Middle East & Africa Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
94 Middle East & Africa Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
95 Middle East & Africa Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
96 Middle East & Africa Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)